NPPA and cardiac hypertrophy: TMAO significantly increased the mRNA and protein levels of the hypertrophic markers atrial natriuretic peptide (ANP) and β-myosin heavy chain (β-MHC), causing myocardial hypertrophy and fibrosis (94).